Nicola Wodlinger, the Chief Executive Officer of mBIOTA Labs, is a leader at the forefront of merging therapeutic nutrition with clinical excellence. With a background in building multi-million dollar brands and a current mission to revolutionize how we treat the gut, Wodlinger advocates for a healthcare model rooted in empathy, integrity, and rigorous science. Her work focuses on challenging the conventional divide between medical treatment and consumer wellness to provide patients with safer, research-driven solutions.
In this discussion, we explore the complexities of the modern patient-provider relationship, the physical dangers of viral health trends like “fibermaxxing,” and the regulatory gaps in the supplement industry. Wodlinger also provides a roadmap for how the healthcare system can evolve to prioritize quality time over patient volume, ensuring that evidence-based nutrition becomes a cornerstone of GI health.
Approximately one-third of patients avoid medical care after feeling dismissed by a provider. How does this cycle of distrust specifically impact long-term GI health outcomes, and what specific communication techniques can practitioners use to validate patient concerns while steering them away from unqualified online advice?
When a patient feels their symptoms are ignored, the resulting avoidance often leads to delayed diagnoses and the progression of chronic conditions that could have been managed earlier. In the GI space, this is particularly dangerous because untreated inflammation or microbial imbalances can worsen over time, leading to more invasive interventions later on. To break this cycle, practitioners must adopt an “open-door” communication style where they acknowledge the patient’s research rather than dismissing it out of hand. By saying, “I see why this trend caught your eye, let’s look at the data together,” a provider validates the patient’s proactive interest in their own health. This collaborative approach creates a safe environment where the patient feels heard, making them less likely to turn to unchecked “health hacks” that lack scientific rigor.
Many patients are gravitating toward holistic options to avoid pharmaceutical side effects. How should clinicians evaluate the safety of “cure-all” supplements that haven’t faced rigorous oversight, and what metrics should they use to determine if a natural alternative is appropriate for a patient’s specific condition?
Clinicians must approach “cure-all” claims with a high degree of skepticism, as these products often bypass the strict clinical trials required for pharmaceuticals. A primary metric for evaluation should be the presence of peer-reviewed research specifically tied to the ingredients and dosages found in the supplement. Providers should also look for third-party certifications that verify the purity and potency of the product to ensure it isn’t contaminated or mislabeled. It is vital to assess how a natural alternative interacts with a patient’s existing treatment plan, as an “all-natural” label does not guarantee a lack of contraindications. Ultimately, the goal is to find evidence-based options that offer the benefits of nutrition without the unmitigated risks of unsubstantiated marketing claims.
Licensed experts are ethically restricted from making blind recommendations, whereas social media influencers operate without such boundaries. How can medical professionals effectively compete with viral trends while maintaining clinical standards, and what are the specific risks when “health hacks” go viral without any qualifying medical context?
Medical professionals can compete by utilizing social media to share evidence-based insights that are accessible but grounded in science, effectively “crowding out” misinformation with high-quality content. The danger of viral “health hacks” lies in their lack of context; a protocol that works for one person might be devastating for another with a different clinical profile. For instance, when advice goes viral without disclaimers, it ignores the unique physiological needs of the individual, leading to a “one-size-fits-all” mentality that is rarely appropriate in medicine. Influencers are not held to the same ethical standards as board-certified experts, which means they can promote products without considering the long-term health consequences for their followers. By providing qualifying medical context, practitioners can help patients understand that what works for a personality on a screen may not be safe for their own body.
Trends like “fibermaxxing” can be physically harmful to the 1 in 9 people living with SIBO or IBS. Can you explain the physiological consequences of adding excess fiber to an unbalanced gut microbiome, and how can providers better identify patients who are self-treating with these popular but inappropriate protocols?
For the 1 in 9 people suffering from SIBO or IBS, “fibermaxxing” can act as fuel for an already overgrown or unbalanced bacterial population, leading to severe gas, painful bloating, and altered motility. Instead of healing the gut, the excess fiber promotes the growth of the very bacteria causing the symptoms, creating a cycle of physical discomfort. Providers can identify patients who are self-treating by asking specific questions about recent changes in diet or the introduction of new supplements during routine check-ups. Many patients may be hesitant to bring up these trends because they fear judgment, so providers must proactively inquire about “wellness routines” they’ve seen online. Identifying these behaviors early allows the practitioner to pivot the patient toward a personalized nutrition plan that addresses the root cause of their GI distress rather than exacerbating it.
Since the supplement industry lacks the same FDA approval process as pharmaceuticals, consumers often carry the burden of assessing risk. What specific red flags should patients look for in marketing claims, and what steps should a provider take if they suspect a supplement is causing liver or kidney damage?
The most significant red flag is the use of the word “cure” or any claim that a product can treat a specific medical condition without FDA backing. Patients should also be wary of products that do not provide a full list of ingredients or those that use “proprietary blends” to hide the actual dosages of active components. If a provider suspects a supplement is causing organ damage, such as liver or kidney stress, they should immediately advise the patient to stop the supplement and order a comprehensive metabolic panel to assess function. It is essential to document these cases and report adverse events to the FDA, as the agency often relies on these reports to take action against harmful products. Educating the patient on the physiological burden of processing unverified substances is a key step in preventing future toxicity.
High patient volumes often prevent doctors from having in-depth discussions about nutrition and lifestyle. How can the healthcare system be restructured to prioritize quality time over patient quantity, and what role do industry partners play in providing the evidence-based resources that busy practitioners currently lack?
Restructuring the healthcare system requires a shift in the reimbursement model to value the time spent on preventive counseling and nutritional education rather than just procedural volume. When providers are forced to see dozens of patients a day, the nuance required for therapeutic nutrition is often lost. Industry partners can bridge this gap by developing “turnkey” evidence-based resources—such as clinical summaries and patient education materials—that practitioners can use to deliver high-quality information quickly. These partners serve as niche experts, providing the data-driven support that allows a busy doctor to offer personalized advice without spending hours on research. By leveraging these external resources, the system can begin to prioritize the quality of the interaction, leading to better long-term outcomes for patients with complex GI needs.
What is your forecast for the future of therapeutic nutrition in the GI space?
I believe we are entering an era where the lines between medicine and nutrition will continue to blur, leading to a “nutritional revolution” where diet is treated as a primary clinical intervention rather than an afterthought. We will see a shift away from generic supplements toward highly targeted, medical-grade nutritional products that are backed by the same level of scientific rigor as pharmaceuticals. As patients become more vocal about their desire for holistic care, the healthcare system will have no choice but to integrate these therapies into standard protocols. Success in this future will depend on building stronger, trust-based relationships between providers and patients, ensuring that every “health hack” is replaced by a science-backed solution. My hope is that through empathy and action, we can create a landscape where patients feel empowered and safely guided through their journey to gut health.
